Government's Weird Enzyme Could Turbocharge Cancer Immune Attacks
Published Date: 10/2/2025
Notice
Summary
The National Cancer Institute has a cool new invention called Acyloxyacyl Hydrolase (AOAH) that could help fight cancer by boosting the immune system. This invention is ready for companies or researchers to license or team up on, speeding up the journey from lab to real-life treatments. If you’re in biotech or cancer research, now’s the time to jump in and make a difference!
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Government AOAH Invention Open For Licensing
The National Cancer Institute (NCI) is offering a government-owned invention called Acyloxyacyl Hydrolase (AOAH) and related methods for licensing or collaboration so companies and researchers can commercialize cancer immunotherapy research. If you run or work for a biotech company or cancer research group, you can pursue a license or collaboration with NCI to develop this federally funded technology.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in